Vaccination-Induced Noncytolytic Effects in the Acute Phase of SHIV Infection by Petravic, Janka & Davenport, Miles P.
Vaccination-Induced Noncytolytic Effects in the Acute
Phase of SHIV Infection
Janka Petravic, Miles P. Davenport*
Complex Systems in Biology Group, Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia
Abstract
Many studies have shown that vaccines inducing CD8+ T cell responses can reduce viral loads and preserve CD4+ T cell
numbers in monkey models of HIV infection. The mechanism of viral control by the vaccine-induced CD8+ T cells is usually
assumed to be cytolysis of infected cells. However, in addition to cytolysis of infected cells, CD8+ T cells secrete a range of
soluble factors that suppress viral replication. We have studied the dynamics of virus and CD4+ T cells in a successful
vaccination-challenge model of SHIV infection. We find that better viral control in the acute phase of infection is associated
with slower decay of peak viral load. Comparing viral and CD4+ T cell dynamics in acute infection, we find that a cytolytic
mode of viral control with direct killing of infected cells is inconsistent with the observed trends. On the other hand,
comparison of the predicted effects of noncytolytic CD8+ effector function with the experimental data shows that non-
cytolytic control provides a better explanation of the experimental results. Our analysis suggests that vaccine-induced CD8+
T cells control SHIV infection by non-cytolytic means.
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Introduction
Virus-specific CD8+ T cells play an important role in control of
HIV-1 infection in humans and simian immunodeficiency virus
(SIV) infection in macaques [1,2,3,4]. After T-cell receptor
interaction with peptide/major histocompatibility class I (MHC-
I) complexes, CD8+ T cells proliferate and express a variety of
effector functions that inhibit viral replication. These include
direct lysis of infected cells [5] and release of a range of cytokines
[6], which may suppress production of new virions by infected
cells, or chemokines [7] inhibiting viral entry into the host cells.
Different types of CD8+ T-cell antiviral activity have been shown
in vivo by FACS sorting of cells expressing different markers in
blood and tissue samples taken from HIV patients and SIV-
infected monkeys [8], and in a range of in vitro experiments
[9,10,11]. There is evidence that multifunctionality of CD8+ T
cells correlates with the level of viral control [8,12], and that HIV
non-progressors exhibit strong noncytolytic response [13]. It is
therefore important to determine which type of CD8+ T cell
effector function is the most important in HIV/SIV control in
vivo. Several studies of SIV dynamics in CD8-depleted rhesus
macaques have addressed this question [2,14,15]. They showed
that the magnitude and rate of rise in viral load following CD8+ T
cell depletion was too rapid to be explained by increased lifespan
of infected cells [2], and that the decay of SIV under antiretroviral
treatment in the chronic phase of infection is not altered in the
absence of CD8+ T cells [14,15]. Similarly, we have recently
demonstrated that the decay rates of wild-type and escape mutant
virus are similar in SHIV infected macaques, and thus the
dynamics of immune escape are inconsistent with cytolytic control
of wild-type virus [16]. These results indicate that direct killing of
infected cells might not be the dominant means of viral control in
the chronic phase of SIV/SHIV infection.
Simian-human immunodeficiency virus (SHIV) infection of
rhesus macaques provides a model for studies of potential
protective ability of vaccines against HIV-1, where a large number
of vaccines have proved effective [17]. Our aim is to determine,
from the dynamics of the early and acute SHIV infection, whether
the early CD8+ T cell response, stimulated by vaccines that
generate cell-mediated immunity, is predominantly cytolytic or
noncytolytic in this animal model.
In a recent paper [18], we have shown that in CXCR4-tropic
SHIV-infected monkeys vaccination significantly reduced peak
viral load and increased the lowest CD4+ T cell count in the acute
phase of infection. Although we demonstrated the decrease in
virus replication in vaccinated animals, we did not identify the
specific mechanism (i.e. the CD8+ T cell effector function)
responsible for this outcome.
Here we investigated the relationship between the peak viral
load and the decay rate of virus in order to determine if the
improved virus control consistently corresponds to increased direct
killing of infected cells, or is better explained as a consequence of
increased noncytolytic effector functions. We found that lower
viral peak was associated with a slower decay of virus after the
peak. The viral peak and the decay rate were positively correlated
across all animals.
Using a modeling approach to investigate the dynamics of virus
and CD4+ T cells, we find that the kinetics of viral load and the
loss of CD4+ T cells to infection are not consistent with a cytolytic
mechanism of CD8+ T cells killing SHIV infected cells. However,
if the mechanisms of CD8+ T cell control were non-cytolytic, or
involved killing of infected cells in a ‘window period’ before they
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15083produced virus, then the modeled dynamics of viral and CD4+ T
cells would be consistent with the experimental data. This suggests
that vaccine-induced virus-specific CD8+ T cells in SHIV
infection control virus using non-cytolytic mechanisms.
Results
Vaccination against SIV and SHIV results in varying degrees of
protection, depending on the type of vaccine, viral strain and
animal model. The effect of improved viral control in early
infection in vaccinated animals can be seen as the decrease in the
peak plasma viral load and reduced loss of CD4+ T cells in
peripheral blood. We have recently shown [18,19] that there is a
strong positive correlation between peak viral load and CD4+ T
cell loss in the acute phase. Peak viral loads are consistently and
significantly lower in vaccinated animals than in unvaccinated
controls.
One limitation in comparing viral decay data in controls and
vaccines is that the animals were vaccinated with a variety of
regimes, some of which (like adenovirus 5) were very effective,
while others (like Alum) were not. This can be seen in the overlap
of viral peaks. In order to take into account the effectiveness of
different vaccines or of the immune response in control animals,
we investigated how the reduction in peak viral load affected viral
decay. Figure 1 shows viral decay rates plotted against corre-
sponding peak viral loads. We found a significant positive
correlation between peak viral load and decay rate (Spearman
r=0.346 and p=0.0418). That is, a more effective immune
response, which led to better control of peak viremia, was actually
associated with slower decay of virus after the peak.
The dynamics of cytolysis
Let us consider the consequences of CD8+ T cell cytolysis, when
the course of the acute phase of infection in different animals
varies only because of different infected cell lifespan. Figure 2A
illustrates the expected relationship between peak viral load and
viral decay rate, when virus is controlled by cytolysis of infected
cells. When death rate of infected cells is sufficiently low, almost all
CD4+ T cells are infected at nadir, so that the decay of virus is
slow and almost exactly reflects the slow death rate of infected
cells. Increasing the death rate (or killing by cytotoxic T
lymphocytes) leads to increased observed decay rate while
decreasing peak (red, pink, purple and dark blue lines in
Figure 2A). However, when the infected cell death rate becomes
very high, the overall level of infection is decreased sufficiently that
the fraction of cells infected at peak is significantly reduced. This
means that there are more uninfected cells available during the
decay phase of virus, immediately after the peak. The observed
rate of viral decay is the net effect of infected cell death balanced
by the rate of new infections being produced. Thus, when the viral
peak is sufficiently reduced, the decay rate slows down because
there are progressively more uninfected cells available for infection
during the decay phase (the light blue line in Figure 2A). This
means that there must be a maximum decay rate for some
intermediate peak viral load, and that the decay rate should
become slower when the peak decreases further.
It is clear from the above reasoning that the correlation between
peak viral load and viral decay rate can be either positive or
negative. We would see a negative correlation when there are very
few remaining uninfected cells, and faster decay is caused by faster
disappearance of infected cells. In the positive correlation regime,
the decay slows down with decreasing viral load because there are
more uninfected cells at peak, thus allowing reinfection to balance
the death of infected cells. Crucially, a positive correlation between
peak viral load and observed viral decay can only occur when the
number of remaining uninfected cells during decay is sufficiently
large.
Our model (Eq.3–5) reproduces this behaviour. Figure 2B shows
the generic dependence of the decay rate (Eq.9) on peak viral load
(Eq.8) for increasing death rate of infected cells (d) (in the direction
of arrows), while Figure 2C shows the corresponding generic
dependence of CD4+ T cell depletion at nadir (1-Tmin/T0)o n
peak viral load. Figures 2B and 2C were obtained using the
method described in the Supplementary Material A. The viral
decay rates in the blue rectangle in Figure 2B are negatively
correlated to the peak, and correspond to more depleted CD4+ T
cells in the blue rectangle in Figure 2C. The yellow rectangle in
Figure 2B represents the observed negative correlation scenario,
which occurs for better preserved CD4+ T cells in the yellow
rectangle in Figure 2C.
The model predicts that the fastest viral decay rate (the
maximum of the curve in Figure 2B) is always at the same level of
depletion of CD4+ T cells (Figure 2C). The argument goes as
follows: increased death rate of infected cells translates into the
decrease of the reproductive ratio at the peak RP, which uniquely
determines the position of the maximum decay rate in Figure 2B
(see Supplementary Material A for demonstration). The maximum
decay rate always occurs for RP<2.15. For RP,2.15 (yellow
rectangle), we expect a positive correlation between peak viral load
and decay rate, and for RP.2.15 (blue rectangle) we expect a
negative correlation.
Since CD4 depletion at nadir depends only on RP (Eq.7), the
maximum level of depletion of CD4+ T cells that we expect to see
with positive correlation between viral peak and decay corre-
sponds to RP<2.15, meaning that CD4 depletion should not
exceed 83%.
SHIV89.6P is a CXCR4-tropic virus that infects all CD4+ T
cells. Therefore, if CD8+ T-cells are predominantly cytolytic and
we have a positive correlation between peak viral load and viral
Figure 1. Correlation between peak and decay of viral load.
Peak viral load and the decay rate of virus after the peak in SHIV89.6P are
positively correlated (Spearman r=0.346 and p=0.0418).
doi:10.1371/journal.pone.0015083.g001
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be higher than 83%. The observed CD4+ T cell depletion at nadir
in control and vaccinated animals is shown in Figure 3A against
peak viral load. Only 7 vaccinated animals (out of 35) show
depletion lower than 83% consistent with the positive correlation
in Figure 1.
In order to determine if these seven animals are actually driving
the positive correlation between viral peak and decay, we removed
them from the data and recalculated the correlation for the
remaining highly depleted animals. Surprisingly, the positive
correlation was then even more significant (Spearman r=0.465
and p=0.0127).
Figure 2. Cytolytic immune response. For cytolytic immune response, the correlation between peak viral load and the decay of virus can be
positive or negative, depending on the level of CD4+ T cell depletion at nadir. (A) Time course of viral load for increasing death rates of infected cells.
CTL killing increases from red to light blue lines. As the lifespan of infected cells decreases (red to dark blue), peak viral load becomes lower, and the
decay after the peak gets faster. However, for very high infected cell death rates (light blue) peak viral load decreases while the decay rate slows
down. (B) Dependence of viral decay rate on peak viral load (black line) is nonmonotonic with positive correlation for high death rates of infected
cells (yellow rectangle) and negative correlation for low death rates (blue rectangle). The arrows show the direction of increased death rate of
infected cells. The black circle and the vertical dashed line mark the position of the maximum virus decay rate. (C) Depletion of CD4+ T cells at nadir is
positively correlated to peak viral load. The black dot and the vertical dashed line mark the peak viral load corresponding to the maximal decay of
virus. The horizontal line shows the CD4+ T cell depletion at nadir corresponding to the maximum decay after the viral peak (,83%). We expect to
see positive correlation between the viral peak and decay after the peak only CD4+ T cell depletion at nadir is lower than ,83% (yellow rectangle). If
CD4 depletion at nadir is higher (blue rectangle), we expect negative correlation between viral peak and decay.
doi:10.1371/journal.pone.0015083.g002
Figure 3. CD4+ T cell depletion at nadir. The observed depletion of CD4+ T cells at nadir is incompatible with the observed positive correlation
between viral peak and decay if we assume that the CD8 response is cytolytic. (A) Dependence of nadir CD4+ depletion in control (full circles) and
vaccinated (open circles) animals on peak viral load. Only the seven points below the dashed horizontal line (with CD4 depletion below 83%) are
consistent with positive correlation in Figure 2. (B) The positive correlation between virus peak and decay remains even when the seven points with
low CD4 depletion are removed.
doi:10.1371/journal.pone.0015083.g003
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Since the dynamics of viral decay and CD4+ T cell depletion
are not consistently described by an immune response that results
in increased killing of infected cells, we explored the consequences
of noncytolytic activity of virus-specific CD8+ T cells. Some
antiviral soluble factors released by CD8+ T cells suppress viral
replication (by decreasing the probability of infection or the rate of
virus production) without killing the infected cells [7]. The
consequence is again the lowering of peak viral load. However,
since the decay rate of virus after the peak reflects the balance of
the death rate of infected cells (which is constant) and the rate of
new infections, we see a fairly constant decay rate for high values
of the peak, as in red, pink and purple lines in Figure 4A.
However, as the viral peak is further reduced, the proportion of
uninfected cells persisting after the peak also increases consider-
ably. This in turn has a consequence of leaving more uninfected
cells available for infection after the peak. Again, since the
observed decay rate is the net balance of the death rate of infected
cells and the rate of new infections, we see slower decay as the
peak is reduced (the light blue line in Figure 4A). In short, we
expect peak viral load and virus decay rate to be always positively
correlated. The dependence of virus decay on peak viral load for
variable infectivity (Figure 4B) or for variable production of virus
by infected cells (Figure 4C) in the model are similar and both
predict a positive correlation between the peak and decay rate of
viral load. The methods for obtaining the curves in Figure 4B and
C are described in the Supplementary Material A.
Comparing cytolytic and non-cytolytic effects
The analysis described above uses only the viral load kinetics in
order to investigate whether the infection dynamics are consistent
with a cytolytic or non-cytolytic model of infection. Here we found
that a cytolytic model could result in either a positive or a negative
relationship between peak viral load and viral decay rate,
depending on the CD4+ T cell level. However, a non-cytolytic
model consistently predicted a positive relationship. Since our
experimental data also included the CD4+ T cell numbers for
each animal, we extended our model to see if we would
simultaneously account for both the viral and CD4+ T cell
dynamics in using the cytolytic and non-cytolytic models. In other
words, we assume that the differences in viral control among
animals mainly arise from differences in the strength of CD8+ T
cell effector function. The differences in CD8+ T cell function
among animals can either result in differences in the death rate of
infected cells (cytolytic model), or in the viral infectivity or viral
production (non-cytolytic models), while the rest of the parameters
vary among the animals in a random manner. The details of the
fitting procedure are explained in the Supplementary Material B
in Figures S1, S2, S3. The summary of the quantitative analysis is
shown in Figure 5 and in Table 1.
In Figure 5A and in Figure S1 we assumed that cytolysis of
infected cells is the main mechanism of virus control, and
determined the model parameter p/c that provided the best fit
to the data. Using the data on the relationship between virus decay
on virus peak, we first estimated the optimal p/c for this data
(shown as a vertical black line with 95% confidence intervals (C.I.)
in grey). We next estimated the optimal value of p/c that would fit
the CD4+ T cell data (shown as a vertical red line with confidence
intervals in pink). It is quite clear that a cytolytic model cannot
simultaneously fit both the viral decay and CD4+ T cell data. This
is because the observed depletion of CD4+ T cells at nadir is too
high to be consistent with the positive correlation between viral
peak and decay. The ratio of virus production to clearance
estimated from the dependence of decay on peak is incompatible
with the estimate from virus peak and CD4 nadir (the grey and the
pink confidence intervals have no overlap).
Figures 5B and C show the results for two non-cytolytic
mechanisms of control. In Figure 5B (and Figure S2) we fit the
model of increasing immune response that partially blocks virus
entry and thus limits the infectivity of the virus. Figure 5C (and
Figure S3) shows the results of fitting the virus and CD4+ T cell
dynamics when we assume that immune response suppresses virus
production. In both cases, we estimated the best-fit parameters for
the viral load data (black/grey) and CD4 T cells (red/pink). In
each case, there is a large overlap in the confidence intervals of
parameters estimated using the viral and CD4+ T cell data,
demonstrating that the same parameters can simultaneously
describe both viral and CD4+ T cell dynamics without any
apparent contradictions.
Thus, our modelling shows that CD8+ T cell mechanisms that
involve cytolysis of virus producing cells are incompatible with the
experimental data, whereas non-cytolytic mechanisms are com-
Figure 4. Noncytolytic immune response. Peak viral load and decay rate of virus are always positively correlated if virus suppression is due to
noncytolytic immune response. (A) Decay rate of viral load after the peak stays almost constant (red, pink and purple lines) for high peak viremia, but
slows down when virus is strongly suppressed (dark and light blue lines). (B) Viral decay rate increases with the increase in virus peak if CD8+ T cells
control virus by decreasing infectivity. (C) A similar monotonic increase of decay rate with virus peak is observed assuming suppression of virus
production.
doi:10.1371/journal.pone.0015083.g004
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infectivity or reduced viral production by infected cells is the more
likely mechanism.
Cytolysis of infected cells before viral production
It has been recently shown [20,21] that in SIV infection some
epitopes from the Gag and Pol proteins are presented on MHC-I
molecules as soon as 2 hours after viral entry into the infected cell,
well before reverse transcription. Gag- and Pol-specific CD8+ T
cells can recognize and eliminate infected cells in vitro almost
immediately [20,21]. Another study has shown that, after the start
of production of new viral proteins (around 12 hours after
infection of the cell), the presence of Nef downregulates the
expression of MHC-I molecules [22], diminishing the probability
of recognition by virus-specific CD8+ T cells. These effects would
create a window period between 2–12 hours after cell infection,
and before virion production, when infected cells can be
recognized and killed most easily. If such ‘‘killing window’’
existed, what would be its impact on infection dynamics?
If infectivity of the virus remained unchanged, the number of
uninfected target cells would remain the same as without any
killing of infected cells. However, the number of infected cells
producing virus would be diminished by the fraction that were
killed before they started production. The viral replication would
Figure 5. Fitting summary. Results of fitting the same parameter to the dependence of viral decay on peak (best estimate shown as black vertical
line with 95% confidence intervals in grey) and to the dependence of CD4 depletion on viral peak (best estimate shown as red vertical line with 95%
confidence intervals in pink) for different mechanisms of virus control. If we assume cytolytic control, the same parameter cannot simultaneously fit
the two dependencies, but for noncytolytic mechanisms it can. A. The ratio of virus production to clearance p/c for cytolysis of infected cells; B. The
ratio of virus production to clearance p/c for CD8 response decreasing infectivity, C. The ratio of infected cell death rate and infectivity d/b if CD8
response decreases virus production, estimated from the dependence of virus decay and the dependence of CD4+ T cell depletion on peak viral load.
doi:10.1371/journal.pone.0015083.g005
Table 1. Results of nonlinear regression fitting of the same parameter from the dependence of virus decay and CD4+ nadir on
virus peak, assuming different mechanisms of immune control.
Effect of CD8+ T cell response Estimated parameter Relationship Best estimate (95% confidence interval)
Increase in d (cytolysis) p/c DV/T0 vs. VP/T0 933.3 (467.7–1096.5) (copies/cell)6day
21
1-Tmin/T0 vs. VP/T0 97.72 (75.86–151.4) (copies/cell)6day
21
Decreased b (noncytolytic) p/c DV vs. VP/T0 112.2 (85.1–263.0) (copies/cell)6day
21
1-Tmin/T0 vs. VP/T0 97.72 (75.86–151.4) (copies/cell)6day
21
Decreased p (noncytolytic) d/b DV vs. VP 3.24610
7 (2.00–6.46)610
7 (copies/mL)
1-Tmin/T0 vs. VP 3.24610
7 (2.88–3.89)610
7 (copies/mL)
doi:10.1371/journal.pone.0015083.t001
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simplest model describing this effect would be the one where the
Eq.4 is replaced by
dI
dt
~ 1{a ðÞ bVT{dI, ð1Þ
where a is the fraction of infected cells killed in the window period.
The solutions for target cells and viral load would then be the same
as in the original model, but with viral production changed from p
to (1-a)p. Thus, the conclusion is that our model of viral load
behavior cannot distinguish between noncytolytic antiviral effects
and infected cell killing in the window period between infection
and the production of viral proteins.
Discussion
After recognition of MHC-bound viral peptides, CD8+ T cells
can kill infected cells and/or release into the environment a
number of soluble factors that limit viral replication. We analysed
the relationships of three main parameters of acute infection –
peak viral load, decay rate of viral load after the peak and CD4+ T
cell nadir, with the aim to identify the dominant mechanism of
CD8+ T cell-mediated virus control in SHIV89.6P infection that
can consistently explain these three aspects of the acute phase
dynamics.
We found that peak viral load and viral decay after the peak
were positively correlated. Detailed analysis of the dynamics of
decay of viral load showed that, if viral control is mediated by
cytolysis of infected cells, the correlation between peak viral load
and decay rate can be either positive or negative. However, the
positive association can only occur when CD4+ T cell depletion is
incomplete (less than ,80%) (Figure 5C). While the experimental
data show positive correlation between viral peak and decay, the
massive depletion of CD4+ T cells at nadir is not consistent with
the observed dynamics (Figure 3). Cytolytic control of SHIV89.6P
infection cannot simultaneously explain the observed relationships
between peak viral load, decay of viral load after the peak and
CD4+ T cell depletion at nadir.
If control of infection is mediated by noncytolytic mechanisms
(such as suppression of new infections or virus production by
infected cells), peak viral load and decay are expected to be always
positively correlated as observed. Moreover, our modelling
demonstrates that both the viral load and CD4+ T cell data are
consistent with a non-cytolytic model.
One limitation of this study is the use of a CXCR4-tropic SHIV
virus that may have different target cell specificity to the typical
CCR5-tropism of HIV. The clear advantage of the SHIV model is
that, since all CD4+ T cells can be infected, we were able to
compare the dynamics of total CD4+ T cells with viral dynamics
in individual hosts, by assuming that the virus infects all CD4+
phenotypes with similar probability, so that the CD4 depletion
measured in blood reflects the depletion in other anatomical
compartments like tissues and lymph nodes. By contrast, in
infection with CCR5-tropic viruses, it is unclear which CD4+ T
cell population is ideal to study in order to understand target cell
availability [23]. However, the key question for this study is not
which cells are infected, but how the CD8+ T cells control
infection. It seems unlikely that the mechanisms of viral control by
CD8+ T cells are completely different between CCR5-tropic and
CXCR4-tropic viruses, since many of the epitopes targeted by
CD8+ T cells are identical, and the viruses have a very similar
decay rate under therapy (suggesting that the major virus-
producing cells are behaving in a similar manner). Moreover,
these results are consistent with recent results suggesting non-
cytolytic control of SIV in vivo following depletion of CD8+ T
cells and therapy during chronic infection [14,15] and during
immune escape [16]. Our study extends this work to suggest that
viral control is also non-cytolytic during acute infection, and that
vaccination does not modify this mechanism.
Our results demonstrate that the relationship between peak viral
load, virus decay rate after the peak, and CD4+ T cell depletion
cannot be simultaneously explained by a cytolytic mechanism of
direct killing of productively infected cells by virus-specific CD8+
T cells. However, we cannot exclude the possibility that cytolysis of
infected cells predominantly takes place in the window period after
virus enters the cell, but before the start of production of viral
proteins. On the other hand, non-cytolytic mechanisms of viral
control involving reduced infectivity or reduced production of
virus are consistent with the experimental data from SHIV
vaccination analyzed here, as well as the results from CD8-
depletion experiments and immune escape kinetics in SIV/SHIV-
infected macaques ([14,15,16]), suggesting that further work is
required to elucidate the cellular and molecular mechanisms by
which vaccine-induced CD8+ T cells can control HIV infection.
Methods
Experimental data
In a previously published study [24], 35 rhesus macaques
(Macaca mulatta) were challenged intravenously with 50% monkey
infectious doses of X4-tropic SHIV89.6P expressing SIVmac239 gag
gene. Fourteen animals in this group were unvaccinated controls,
while 21 were vaccinated with a variety of regimens, consisting of
SIV gag-containing plasmid DNA (with different adjuvants),
modified vaccinia Ankara, and adenovirus type 5 vectors, as
previously reported. All animals were genotyped for the MHC
class I Manu-A*01 allele presenting the immunodominant SIV gag
epitope p11CM. All but one of the vaccinated animals and 6 out of
14 control animals were positive for this allele. The vaccinated
animals were challenged at 6 weeks or at 12 weeks after the final
boost. Viral loads and CD4+ T-cell counts were monitored in
peripheral blood every 2 to 4 days until 4 weeks after infection and
then weekly.
Data analysis
We use experimental data for the acute peak viral load, the
CD4+ T cell nadir and the maximum decay rate of the viral load
after the peak. The peak viral load is the highest measured value of
viral load during 4 weeks post infection and the target cell nadir is
the lowest CD4+ T cell count within 10 days after the peak viral
load. We define the exponential decay rate DV of viral load
between two measurements at t1 and t2 as:
DV~
lnVt 1 ðÞ {lnVt 2 ðÞ
t2{t1
ð2Þ
We calculate the decay rates for all the intervals for 2 weeks after
the peak viral load, and use the maximum value. In all cases this
maximum decay rate is calculated over time intervals of 3 or 4
days.
Model
Mathematical models of viral dynamics have been successfully
used to study HIV infection [25]. Here we adapt the standard
model of viral dynamics [26,27,28,29], using its reduced form
[18,19] to describe the behavior of uninfected (T) and infected (I)
Noncytolytic Effects from SHIV Vaccines
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where we have access to both viral load and CD4+ T cell number.
The reduced standard model consists of equations
dT
dt
~{bVT ð3Þ
dI
dt
~bVT{dI ð4Þ
dV
dt
~pI{cV: ð5Þ
The infectivity b is the rate at which target cells become infected
at unit virus concentration, and d is the death rate of infected cells.
Free virus is produced by infected cells at rate p and is cleared at
rate c. The dynamics of replacement and death of uninfected
target cells are important for their recovery after the nadir, but can
be neglected in the description of infection between peak viral load
and target cell nadir (where the rate of viral load decline is the
fastest) [18,26]. Thus Eqs.3–5 provide a good model of the
correlations between viral peak and decay and target cell nadir in
CXCR4-tropic infection.
In this model, cellular immune response can affect the death
rate of infected cells d (by killing of infected cells by cytotoxic T
lymphocytes), infectivity b (by blocking viral entry) and production
p (by suppression of virus production by infected cells).
We assume that infection-dependent parameters (b, d, p and c)
are approximately constant between peak viral load and the nadir
of CD4+ T cells. Since the parameters in fact change in time
because of change in immune response, this amounts to assuming
that immune response does not change much during this period of
approximately 10 days. If T0 is the baseline CD4 number, the
course of acute infection in this period is characterized by the
reproductive ratio at the peak RP,
RP~T0
bp
dc
ð6Þ
The reproductive ratio at the peak represents the number of
infected cells generated by one infected cell during its lifetime,
assuming the average level of immune response present between
the peak and the nadir. It is a measure of virus replication in this
period.
In the reduced standard model, the nadir of uninfected cells
Tmin is the solution of the equation [18]
Tmin
T0
{
1
RP
ln
Tmin
T0
~1, ð7Þ
Peak viral load can be expressed as
VP~T0
p
c
1{
1
RP
{
lnRP
RP

: ð8Þ
The fastest decay rate of viral load after the peak DV is at the
nadir of CD4+ T cells [26],
DV~d{b
p
c
Tmin: ð9Þ
The reproductive ratio at the peak RP will differ among animals
(e.g. with vaccination) because of the differences in the strength of
their immune response, which translates into differences in some
of the immunity-dependent parameters d, b,o rp. We shall analyse
the predictions of these relationships assuming that the differences
in viral control among animals mainly arise from differences in a
single CD8+ T cell effector function, which either changes the
lifespan of infected cells, or viral infectivity or production. In the
model terms, this would translate into the interdependencies of
viral peak and decay and target cell nadir, if the differences in RP
among animals arise predominantly because of the differences in
only one parameter (d for cytolytic control or b,o rp for
noncytolytic effects). Using the model predictions, we shall
determine which CD8 effector function best reproduces the
observed viral and CD4+ T cell dynamics in the acute phase of
infection.
Supporting Information
Figure S1 Effects of cytolytic response. The ratio of viral
production and clearance (p/c) cannot be consistently determined
from experimental data for viral peak and decay and CD4
depletion if we assume cytolytic immune response. (A) Model
prediction for dependence of decay rate on viral peak and the
method for fitting to experimental data. The dependence is
nonmonotonic with positive correlation for low peaks and negative
correlation for higher peaks (black line). Increasing p/c shifts the
curve in x-direction without changing its shape (red lines), while
increasing the replicative capacity bp/c increases the maximum
without shifting its position. (B) Best fit for p/c and bp/c from the
dependence of virus decay on virus peak (both scaled by the
baseline target cell number) is shown as black line. The envelope of
confidence intervals for the two parameters is in grey. Because of
the overall positive correlation between viral peak and decay, the
best-fit p/c moves the position of maximum decay rate to the peak
viral load higher than observed in most of the animals. Best fit (red
line) and confidence intervals (pink) for replicative capacity when
p/c is constrained to the best fit of peak – target nadir dependence.
(C) Model prediction for dependence of CD4+ T cell depletion at
nadir on viral peak and the method for fitting to experimental
data. The basic shape of the dependence (black line) is parameter-
independent and the increase in p/c shifts the curve in x-direction
without changing its shape (red lines). (D) Best fit (red line) and
confidence intervals (pink) for p/c determined from the depen-
dence of CD4+ T cell depletion on peak viral load. Best fit and
confidence intervals for p/c from peak – decay dependence are
shown for comparison (black line and grey area respectively). Most
data points lie on the left hand side of the curve in order to fit the
negative correlation in (B). Red and black dashed lines in (B) and
(D) show the peak viral load corresponding to the maximum viral
decay rate for each fit.
(TIF)
Figure S2 Effects of reduced viral infectivity on the behaviour of
viral load and CD4+ T cell depletion. The same ratio of virus
production to clearance (p/c) fits the experimental data for the
dependence of viral decay on peak and the dependence of CD4
depletion on viral peak if we assume that immune response limits
virus infectivity. (A) Best fit for p/c and death rate of infected cells
(d) from the dependence of virus decay on virus peak (scaled by
CD4+ T cell number) is shown as black line. The envelope of
confidence intervals for the two parameters is in grey. Best fit (red
line) and confidence intervals (pink) for d when p/c is constrained
to the best fit of dependence CD4+ nadir on virus peak. (B) Best fit
Noncytolytic Effects from SHIV Vaccines
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e15083(red line) and confidence intervals (pink) for p/c determined from
the dependence of CD4+ T cell depletion on peak viral load
(scaled by baseline target cell number). Best fit and confidence
intervals for p/c from peak – decay dependence are shown for
comparison (black line and grey area respectively).
(TIF)
Figure S3 Effects of decreased virus production on the
behaviour of viral load and CD4+ T cell depletion. The same
ratio of infected cells death rate to infectivity (d/b) fits the
experimental data for the dependence of viral decay on peak and
the dependence of CD4 depletion on viral peak if we assume that
immune response suppresses virus production rate. (A) Best fit for
d/b and infected cells death rate (d) from the dependence of virus
decay on virus is shown as black line. The envelope of confidence
intervals for the two parameters is in grey. Best fit (red line) and
confidence intervals (pink) for d when b/d is constrained to the
best fit of dependence CD4+ nadir on virus peak. (B) Best fit (red
line) and confidence intervals (pink) for b/d determined from the
dependence of CD4+ T cell depletion on peak viral load. Best fit
and confidence intervals for b/d from peak – decay dependence
are shown for comparison (black line and grey area respectively).
(TIF)
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